Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
3D-printed boluses for radiotherapy: influence of geometrical and printing parameters on dosimetric characterization and air gap evaluation.
Gugliandolo SG, Pillai SP, Rajendran S, Vincini MG, Pepa M, Pansini F, Zaffaroni M, Marvaso G, Alterio D, Vavassori A, Durante S, Volpe S, Cattani F, Jereczek-Fossa BA, Moscatelli D, Colosimo BM. Gugliandolo SG, et al. Among authors: pansini f. Radiol Phys Technol. 2024 Jun;17(2):347-359. doi: 10.1007/s12194-024-00782-1. Epub 2024 Feb 13. Radiol Phys Technol. 2024. PMID: 38351260 Free PMC article.
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
Piperno G, Ferrari A, Volpe S, Cattani F, Zaffaroni M, Comi S, Pansini F, Bergamaschi L, Mazzola GC, Ceci F, Colandrea M, Petralia G, Orecchia R, Jereczek-Fossa BA, Alterio D. Piperno G, et al. Among authors: pansini f. Crit Rev Oncol Hematol. 2023 Nov;191:104114. doi: 10.1016/j.critrevonc.2023.104114. Epub 2023 Sep 6. Crit Rev Oncol Hematol. 2023. PMID: 37683814 Review.
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparison.
Cambria R, Ciardo D, Bazani A, Pansini F, Rondi E, Maestri D, Zerini D, Marvaso G, Romanelli P, Timon G, Fodor C, Petralia G, Alessi S, Pricolo P, Vischioni B, Fossati P, Molinelli S, Russo S, Ciocca M, De Cobelli O, Renne G, Orecchia R, Cattani F, Jereczek-Fossa BA. Cambria R, et al. Among authors: pansini f. Tumori. 2022 Jun;108(3):263-269. doi: 10.1177/03008916211011667. Epub 2021 Apr 25. Tumori. 2022. PMID: 33896239
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience.
Augugliaro M, Marvaso G, Cambria R, Pepa M, Bagnardi V, Frassoni S, Pansini F, Patricia Rojas D, Colombo F, Iuliana Fodor C, Musi G, Petralia G, De Cobelli O, Cattani F, Orecchia R, Zerini D, Jereczek-Fossa BA. Augugliaro M, et al. Among authors: pansini f. Phys Med. 2021 Dec;92:62-68. doi: 10.1016/j.ejmp.2021.11.005. Epub 2021 Dec 3. Phys Med. 2021. PMID: 34871888
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach.
Marvaso G, Jereczek-Fossa BA, Riva G, Bassi C, Fodor C, Ciardo D, Cambria R, Pansini F, Zerini D, De Marco P, Cattani F, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: pansini f. Clin Genitourin Cancer. 2017 Jun;15(3):376-383. doi: 10.1016/j.clgc.2017.01.007. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28190704 Clinical Trial.
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218.
Timon G, Ciardo D, Bazani A, Marvaso G, Riva G, Volpe S, Rojas DP, Renne G, Petralia G, Zerini D, Fodor C, Dicuonzo S, Maestri D, Pansini F, Cambria R, Cattani F, Golino F, Scroffi V, De Lorenzo D, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: pansini f. Br J Radiol. 2018 Sep;91(1089):20160725. doi: 10.1259/bjr.20160725. Epub 2018 May 23. Br J Radiol. 2018. PMID: 29750539 Free PMC article. Clinical Trial.
93 results